Skip to main content
Premium Trial:

Request an Annual Quote

Luminex May Pick New CFO Next Week

NEW YORK, March 12 - Luminex may pick a new money man as early as next week.

An official at the Austin, Texas-based bead-array developer told GenomeWeb on Wednesday that the company's board may name a new chief financial officer at a meeting next week.

Luminex said in a terse memo released on March 4 that CFO Frank Reeves had left the company after less than one year on the job. In an interview today, Randy Marfin, vice president of business development, said the abrupt departure was due to personal rather than performance-related reasons.

 

Harriss Currie, acting controller and treasure at Luminex, has been interim CFO, Marvin said. Currie, 40, who has been helped by Kevin McNamara, a corporate consultant, will likely get the nod to take over Reeves' post full time.
"Harriss has been acting as a CFO and it's quite possible that he could be the CFO," said Marvin.

The Scan

Ancient Greek Army Ancestry Highlights Mercenary Role in Historical Migrations

By profiling genomic patterns in 5th century samples from in and around Himera, researchers saw diverse ancestry in Greek army representatives in the region, as they report in PNAS.

Estonian Biobank Team Digs into Results Return Strategies, Experiences

Researchers in the European Journal of Human Genetics outline a procedure developed for individual return of results for the population biobank, along with participant experiences conveyed in survey data.

Rare Recessive Disease Insights Found in Individual Genomes

Researchers predict in Genome Medicine cross-population deletions and autosomal recessive disease impacts by analyzing recurrent nonallelic homologous recombination-related deletions.

Genetic Tests Lead to Potential Prognostic Variants in Dutch Children With Dilated Cardiomyopathy

Researchers in Circulation: Genomic and Precision Medicine found that the presence of pathogenic or likely pathogenic variants was linked to increased risk of death and poorer outcomes in children with pediatric dilated cardiomyopathy.